AC T31896
XX
ID T31896
XX
DT 10.03.2005 (created); nvo.
DT 21.06.2016 (updated); mom.
CO Copyright (C), QIAGEN.
XX
FA VDR
XX
SY Vitamin D3 Receptor.
XX
OS Mammalia
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia
XX
IN T30262 alpha-actinin-4-isoform3; human, Homo sapiens.
IN T09446 c-Jun; Mammalia.
IN T10677 FOXO3a; Mammalia.
IN T09632 FXR; human, Homo sapiens.
IN T14288 PLZF; Mammalia.
IN T09964 RXR-alpha; Mammalia.
IN T30703 SIRT1; Mammalia.
IN T08728 SKIP; human, Homo sapiens.
IN T08326 Sp1; Mammalia.
IN T21552 SRC-1; Mammalia.
IN T23076 STAT1; Mammalia.
XX
MX M00966 V$DR3_Q4.
MX M00444 V$VDR_Q3.
MX M00961 V$VDR_Q6.
MX M03569 V$VDR_Q6_01.
XX
BS R73578.
BS R66795.
BS R66794.
BS R10068.
XX
DR TRANSPATH: MO000047518.
DR TRANSCOMPEL: C00076.
XX
RN [1]; RE0016437.
RX PUBMED: 9632709.
RA Baudino T. A., Kraichely D. M., Jefcoat SC J. r., Winchester S. K., Partridge N. C., MacDonald P. N.
RT Isolation and characterization of a novel coactivator protein, NCoA-62, involved in vitamin D-mediated transcription
RL J. Biol. Chem. 273:16434-16441 (1998).
RN [2]; RE0027377.
RX PUBMED: 11104746.
RA Ohsawa M., Koyama T., Yamamoto K., Hirosawa S., Kamei S., Kamiyama R.
RT 1alpha,25-dihydroxyvitamin D(3) and its potent synthetic analogs downregulate tissue factor and upregulate thrombomodulin expression in monocytic cells, counteracting the effects of tumor necrosis factor and oxidized LDL
RL Circulation 102:2867-72 (2000).
RN [3]; RE0032223.
RX PUBMED: 14729647.
RA Ji Y., Studzinski G. P.
RT Retinoblastoma protein and CCAAT/enhancer-binding protein beta are required for 1,25-dihydroxyvitamin D3-induced monocytic differentiation of HL60 cells.
RL Cancer Res. 64:370-7 (2004).
RN [4]; RE0035930.
RX PUBMED: 15456860.
RA Paredes R., Arriagada G., Cruzat F., Villagra A., Olate J., Zaidi K., van Wijnen A., Lian J. B., Stein G. S., Stein J. L., Montecino M.
RT Bone-specific transcription factor Runx2 interacts with the 1alpha,25-dihydroxyvitamin D3 receptor to up-regulate rat osteocalcin gene expression in osteoblastic cells.
RL Mol. Cell. Biol. 24:8847-8861 (2004).
RN [5]; RE0038476.
RX PUBMED: 12089346.
RA Maeda Y., Rachez C., Hawel L. 3rd, Byus C. V., Freedman L. P., Sladek F. M.
RT Polyamines modulate the interaction between nuclear receptors and vitamin D receptor-interacting protein 205
RL Mol. Endocrinol. 16:1502-10 (2002).
RN [6]; RE0038958.
RX PUBMED: 9168930.
RA Imai T., Matsuda K., Shimojima T., Hashimoto T., Masuhiro Y., Kitamoto T., Sugita A., Suzuki K., Matsumoto H., Masushige S., Nogi Y., Muramatsu M., Handa H., Kato S.
RT ERC-55, a binding protein for the papilloma virus E6 oncoprotein, specifically interacts with vitamin D receptor among nuclear receptors
RL Biochem. Biophys. Res. Commun. 233:765-9 (1997).
RN [7]; RE0039253.
RX PUBMED: 10967105.
RA Guzey M., Takayama S., Reed J. C.
RT BAG1L enhances trans-activation function of the vitamin D receptor
RL J. Biol. Chem. 275:40749-56 (2000).
RN [8]; RE0040648.
RX PUBMED: 10681591.
RA Leo C., Li H., Chen J. D.
RT Differential mechanisms of nuclear receptor regulation by receptor-associated coactivator 3
RL J. Biol. Chem. 275:5976-82 (2000).
RN [9]; RE0042096.
RX PUBMED: 14637167.
RA Sakuma T., Miyamoto T., Jiang W., Kakizawa T., Nishio S. I., Suzuki S., Takeda T., Oiwa A., Hashizume K.
RT Inhibition of peroxisome proliferator-activated receptor alpha signaling by vitamin D receptor
RL Biochem. Biophys. Res. Commun. 312:513-9 (2003).
RN [10]; RE0042695.
RX PUBMED: 11386849.
RA Malloy P. J., Zhu W., Zhao X. Y., Pehling G. B., Feldman D.
RT A novel inborn error in the ligand-binding domain of the vitamin D receptor causes hereditary vitamin D-resistant rickets
RL Mol. Genet. Metab. 73:138-48 (2001).
RN [11]; RE0043039.
RX PUBMED: 9831079.
RA Masuyama H., MacDonald P. N.
RT Proteasome-mediated degradation of the vitamin D receptor (VDR) and a putative role for SUG1 interaction with the AF-2 domain of VDR
RL J. Cell. Biochem. 71:429-40 (1998).
RN [12]; RE0044052.
RX PUBMED: 10753860.
RA Chiba N., Suldan Z., Freedman L. P., Parvin J. D.
RT Binding of liganded vitamin D receptor to the vitamin D receptor interacting protein coactivator complex induces interaction with RNA polymerase II holoenzyme
RL J. Biol. Chem. 275:10719-22 (2000).
RN [13]; RE0044452.
RX PUBMED: 15225812.
RA Lezot F., Coudert A., Petit S., Vi-Fane B., Hotton D., Davideau J. L., Kato S., Descroix V., Pibouin L., Berdal A.
RT Does Vitamin D play a role on Msx1 homeoprotein expression involving an endogenous antisense mRNA?
RL J. Steroid Biochem. Mol. Biol. 89:413-7 (2004).
RN [14]; RE0045701.
RX PUBMED: 12445200.
RA Bikle D. D., Ng D., Oda Y., Hanley K., Feingold K., Xie Z.
RT The vitamin D response element of the involucrin gene mediates its regulation by 1,25-dihydroxyvitamin D3
RL J. Invest. Dermatol 119:1109-13 (2002).
RN [15]; RE0046381.
RX PUBMED: 11913978.
RA Cao L. P., Bolt M. J., Wei M., Sitrin M. D., Chun Li Y.
RT Regulation of calbindin-D9k expression by 1,25-dihydroxyvitamin D(3) and parathyroid hormone in mouse primary renal tubular cells
RL Arch. Biochem. Biophys. 400:118-24 (2002).
RN [16]; RE0051114.
RX PUBMED: 12016314.
RA Makishima M., Lu T. T., Xie W., Whitfield G. K., Domoto H., Evans R. M., Haussler M. R., Mangelsdorf D. J.
RT Vitamin D receptor as an intestinal bile acid sensor.
RL Science 296:1313-1316 (2002).
RN [17]; RE0051190.
RX PUBMED: 16522742.
RA Honjo Y., Sasaki S., Kobayashi Y., Misawa H., Nakamura H.
RT 1,25-dihydroxyvitamin D3 and its receptor inhibit the chenodeoxycholic acid-dependent transactivation by farnesoid X receptor.
RL J. Endocrinol. 188:635-643 (2006).
RN [18]; RE0053005.
RX PUBMED: 18358842.
RA Ajima R., Akiyama T., Usui M., Yoneda M., Yoshida Y., Nakamura T., Minowa O., Noda M., Tanaka S., Noda T., Yamamoto T.
RT Osteoporotic bone formation in mice lacking tob2; involvement of Tob2 in RANK ligand expression and osteoclasts differentiation.
RL FEBS Lett. 582:1313-1318 (2008).
RN [19]; RE0053013.
RX PUBMED: 15176999.
RA Kurihara N., Reddy S. V., Araki N., Ishizuka S., Ozono K., Cornish J., Cundy T., Singer F. R., Roodman G. D.
RT Role of TAFII-17, a VDR binding protein, in the increased osteoclast formation in Paget's Disease.
RL J. Bone Miner. Res. 19:1154-1164 (2004).
RN [20]; RE0053416.
RX PUBMED: 11514567.
RA Zhang C., Baudino T. A., Dowd D. R., Tokumaru H., Wang W., MacDonald P. N.
RT Ternary complexes and cooperative interplay between NCoA-62/Ski-interacting protein and steroid receptor coactivators in vitamin D receptor-mediated transcription.
RL J. Biol. Chem. 276:40614-40620 (2001).
RN [21]; RE0053648.
RX PUBMED: 11719366.
RA Ward J. O., McConnell M. J., Carlile G. W., Pandolfi P. P., Licht J. D., Freedman L. P.
RT The acute promyelocytic leukemia-associated protein, promyelocytic leukemia zinc finger, regulates 1,25-dihydroxyvitamin D(3)-induced monocytic differentiation of U937 cells through a physical interaction with vitamin D(3) receptor.
RL Blood 98:3290-3300 (2001).
RN [22]; RE0053683.
RX PUBMED: 16753019.
RA Nguyen M., d'Alesio A., Pascussi J. M., Kumar R., Griffin M. D., Dong X., Guillozo H., Rizk-Rabin M., Sinding C., Bougneres P., Jehan F., Garabedian M.
RT Vitamin D-resistant rickets and type 1 diabetes in a child with compound heterozygous mutations of the vitamin D receptor (L263R and R391S): dissociated responses of the CYP-24 and rel-B promoters to 1,25-dihydroxyvitamin D3.
RL J. Bone Miner. Res. 21:886-894 (2006).
RN [23]; RE0070207.
RX PUBMED: 20733005.
RA An B. S., Tavera-Mendoza L. E., Dimitrov V., Wang X., Calderon M. R., Wang H. J., White J. H.
RT Stimulation of Sirt1-regulated FoxO protein function by the ligand-bound vitamin D receptor.
RL Mol. Cell. Biol. 30:4890-4900 (2010).
XX
//